ScinoPharm Taiwan Ltd
TWSE:1789

Watchlist Manager
ScinoPharm Taiwan Ltd Logo
ScinoPharm Taiwan Ltd
TWSE:1789
Watchlist
Price: 22.6 TWD 1.12%
Market Cap: 17.9B TWD
Have any thoughts about
ScinoPharm Taiwan Ltd?
Write Note

ScinoPharm Taiwan Ltd
Investor Relations

ScinoPharm Taiwan Ltd. engages in the research, development, manufacturing, and sales of active pharmaceutical ingredients and injections. The company is headquartered in Tainan, Tainan. The company went IPO on 2010-10-29. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The firm is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The firm operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Chih-Hsien Lo
Chairman & General Chief Strategy Officer
No Bio Available
Ms. Li-An Lu
President & CEO
No Bio Available
Ms. Chih-Hui Lin
Acting Financial Off., Senior Director of Acct., Acct. Off., Acting Spokesperson & Corp. Gov. Off.
No Bio Available
Mr. Ling-Hsiao Lien
Vice-President of Marketing, Sales & Operations
No Bio Available
Dr. Li-Chiao Chang Chemistry, Ph.D.
VP of R&D Division and Chief Scientific Officer
No Bio Available
Mr. Jason Chen
Director of Human Resources & Admin
No Bio Available
Mr. Shun Yang Lin
Director of Corporate Development
No Bio Available

Contacts

Address
TAINAN
Tainan
No.1, Nan-Ke 8th Road, Southern Taiwan Science Park, Shan-Hua District
Contacts